BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7440813)

  • 1. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating keratoacanthoma from squamous cell carcinoma of the lower lip: an analysis of intraepithelial elastic fibers and intracytoplasmic glycogen.
    Ellis GL
    Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):527-32. PubMed ID: 6580597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 5. Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.
    Shah K; Kazlouskaya V; Lal K; Molina D; Elston DM
    J Cutan Pathol; 2014 Feb; 41(2):108-12. PubMed ID: 24138600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
    Nagarajan P
    J Cutan Pathol; 2020 Apr; 47(4):418-420. PubMed ID: 31893469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of actinically damaged elastic fibers in keratoacanthomas: an aid in diagnosis.
    Jordan RC; Kahn HJ; From L; Jambrosic J
    J Cutan Pathol; 1991 Apr; 18(2):81-6. PubMed ID: 1856347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
    Schnur PL; Bozzo P
    Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
    Goldenhersh MA; Olsen TG
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
    Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
    Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical sweat duct hyperplasia accompanying keratoacanthoma.
    Santa Cruz DJ; Clausen K
    Dermatologica; 1977; 154(3):156-60. PubMed ID: 856645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin.
    Kern WH; McCray MK
    J Cutan Pathol; 1980 Oct; 7(5):318-25. PubMed ID: 7430483
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of errors in the diagnosis of keratoacanthoma].
    Peszyński J; Czuczwar S; Zurawska-Poleszak S
    Przegl Dermatol; 1971; 58(6):743-8. PubMed ID: 5139314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Keratoacanthoma? Better to say "squamous cell carcinoma, keratoacanthoma type"].
    Cribier B
    Ann Dermatol Venereol; 2008; 135(8-9):541-6. PubMed ID: 18789286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.